Advertisement
<< Back To Article
New Hep C Treatment Guidelines Spell Out Incivek and Victrelis Use

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

3 Comments

Hep Editors

For more conversation on this topic please visit the Forums... forums.hepmag.com/index.php?topic=990

October 19, 2011 New York

Tim Horn, Hep EIC

Kevin, at a conference nearly 2.5 years ago, Vertex (maker of Incivek) reported that Victrelis is active against genotype 4. Unfortunaely, we don't know a lot about Victrelis for genotype 4 though. Also, you may be eligible for clinical trials testing new drugs for genotype 4. Go to clinicaltrials.gov and search for BMS-790052 and BMS-650032. You may not qualify, because of your cancer history, but you should definitely inquire.

October 18, 2011 New York, NY

Kevin Carney

Hello,I am seeking better info on hep c genome 4.(which i have)I have basically been on hold regarding treatment,waiting for my docs to say that the new meds can be used for genome 4 patients. I have been told that the rareness of genome 4 people means lack of testing results for them. Previous cancer issues(now cleared) indicate that the new drugs would allow me to have a safer and shorter course, but Im at a loss for answers. Any info you could share would help.

October 14, 2011 Alstead NH

Advertisement

Hot topics


Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.